Compare Neurocrine Biosciences Inc (NBIX) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Twilio Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Twilio Inc trades at $195 (market cap $31.15B). The key difference: Twilio Inc is the larger of the two by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Twilio Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | TWLO | |
|---|---|---|
Market Cap | $17.40B | $31.15B |
Sector | Health | Technology |
52-Week High | $180.55 | $236.64 |
52-Week Low | $123.10 | $92.44 |
Enterprise Value | $16.49B | $29.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
